Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR.

EGFR mutations circulating tumor DNA (ctDNA) circulating tumor cells (CTC) crystal digital PCR liquid biopsy osimertinib

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
31 May 2021
Historique:
received: 05 04 2021
revised: 13 05 2021
accepted: 27 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Circulating tumor DNA (ctDNA) analysis has clinical utility in EGFR mutant NSCLC. Circulating tumor cells (CTCs) consist a unique source of information at the cellular level. Digital PCR (dPCR) is a valuable tool for accurate and valid analysis of gene mutations in liquid biopsy analysis. In the present study we detected EGFR mutations in ctDNA and paired CTCs under osimertinib therapy at two time points using crystal dPCR and the naica

Identifiants

pubmed: 34073111
pii: cancers13112736
doi: 10.3390/cancers13112736
pmc: PMC8197887
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Stavros Niarchos Foundation
ID : 16785

Références

Sci Rep. 2021 Jan 27;11(1):2313
pubmed: 33504904
Nat Med. 2015 Jun;21(6):560-2
pubmed: 25939061
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
Cell Rep Med. 2020 Apr 21;1(1):
pubmed: 32483558
J Thorac Oncol. 2018 Jun;13(6):821-830
pubmed: 29505901
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
Crit Rev Oncol Hematol. 2020 Jul;151:102978
pubmed: 32428812
Oncotarget. 2019 Feb 12;10(13):1345
pubmed: 30863495
Clin Chem. 2019 May;65(5):623-633
pubmed: 30792266
Transl Lung Cancer Res. 2020 Oct;9(5):1795-1809
pubmed: 33209602
J Thorac Dis. 2017 Oct;9(Suppl 13):S1346-S1358
pubmed: 29184673
Trends Mol Med. 2020 May;26(5):519-528
pubmed: 32359482
Clin Cancer Res. 2015 Aug 1;21(15):3552-60
pubmed: 25882755
Front Oncol. 2020 Oct 08;10:572895
pubmed: 33117705
Br J Cancer. 2020 Oct;123(9):1437-1444
pubmed: 32782293
Clin Chem. 2020 Jan 1;66(1):149-160
pubmed: 31628139
PLoS One. 2017 Aug 22;12(8):e0183319
pubmed: 28829811
Sci Rep. 2018 May 9;8(1):7375
pubmed: 29743667
Transl Lung Cancer Res. 2020 Apr;9(2):239-245
pubmed: 32420063
Expert Rev Mol Diagn. 2021 Jan;21(1):63-75
pubmed: 33270495
Clin Cancer Res. 2012 Apr 15;18(8):2391-401
pubmed: 22492982
Nat Commun. 2021 Mar 19;12(1):1780
pubmed: 33741979
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Lancet Oncol. 2016 May;17(5):577-89
pubmed: 27083334
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9236-41
pubmed: 10430926
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
Clin Cancer Res. 2016 Dec 15;22(24):6010-6020
pubmed: 27281561
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
Clin Chem. 2020 Aug 1;66(8):1012-1029
pubmed: 32746458
Clin Chem. 2021 Mar 31;67(4):631-641
pubmed: 33491069
Nat Methods. 2006 Jul;3(7):551-9
pubmed: 16791214
Clin Chem. 2018 Oct;64(10):1522-1533
pubmed: 30018056
Nat Rev Genet. 2019 Feb;20(2):71-88
pubmed: 30410101
Lancet Oncol. 2016 Dec;17(12):1643-1652
pubmed: 27751847
Ann Transl Med. 2017 Feb;5(3):46
pubmed: 28251125
Adv Biosyst. 2020 Aug;4(8):e2000110
pubmed: 32700450
J Thorac Oncol. 2018 Sep;13(9):1248-1268
pubmed: 29885479
N Engl J Med. 2015 Apr 30;372(18):1689-99
pubmed: 25923549
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Target Oncol. 2019 Apr;14(2):197-203
pubmed: 30810887
Clin Cancer Res. 2019 Aug 1;25(15):4691-4700
pubmed: 30988079
Clin Chem. 2011 Aug;57(8):1169-77
pubmed: 21700955
J Thorac Oncol. 2017 Nov;12(11):1728-1732
pubmed: 28843359
Target Oncol. 2019 Jun;14(3):343-350
pubmed: 31161597
Clin Cancer Res. 2016 Mar 1;22(5):1103-10
pubmed: 26446944
Ann Oncol. 2020 Nov;31(11):1536-1544
pubmed: 32861806
Ann Oncol. 2019 Oct 1;30(10):1580-1590
pubmed: 31373349
Nat Rev Clin Oncol. 2021 May;18(5):297-312
pubmed: 33473219
Cancer Discov. 2015 Jul;5(7):713-22
pubmed: 25934077
Lung Cancer. 2015 Dec;90(3):509-15
pubmed: 26494259
N Engl J Med. 2008 Jul 24;359(4):366-77
pubmed: 18596266
PLoS One. 2014 Aug 19;9(8):e103883
pubmed: 25137181
Lancet Oncol. 2012 Mar;13(3):239-46
pubmed: 22285168
Lung Cancer. 2019 Aug;134:187-193
pubmed: 31319980
Biomol Detect Quantif. 2016 Nov 03;10:34-46
pubmed: 27990348
Clin Chem Lab Med. 2019 Apr 24;57(5):e97-e101
pubmed: 30267626
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
JCO Precis Oncol. 2019 Dec;3:1-9
pubmed: 35100738

Auteurs

Aliki Ntzifa (A)

Analysis of Circulating Tumor Cells Lab, Lab of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.

Athanasios Kotsakis (A)

Department of Medical Oncology, General University Hospital of Larissa, 41110 Larissa, Greece.

Vassilis Georgoulias (V)

Hellenic Oncology Research Group (HORG), 11471 Athens, Greece.

Evi Lianidou (E)

Analysis of Circulating Tumor Cells Lab, Lab of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.

Classifications MeSH